Urological Cancers
Contributor(s): Waxman, Jonathan [editor.] | SpringerLink (Online service).
Material type:
BookPublisher: London : Springer London, 2005.Description: XVI, 342 p. 45 illus., 31 illus. in color. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9781846280153.Subject(s): Medicine | Oncology | Urology | Medicine & Public Health | Urology | OncologyDDC classification: 616.6 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
E books
|
PK Kelkar Library, IIT Kanpur | Available | EBK1090 |
Prostate Cancer -- The Molecular Biology of Prostate Cancer -- Familial Prostate Cancer -- Screening for Prostate Cancer -- Diet and Prostate Cancer -- Radical Radiotherapy for Prostate Cancer -- Prostate Cancer: Immediate vs. Deferred Treatment -- Surgical Treatment of Prostate Cancer -- Hormone Therapy for Prostate Cancer -- Chemotherapy in Prostate Cancer -- Proteomic Approaches to Problem Solving in Prostate Cancer -- Gene Therapy for Prostate Cancer -- Bladder Cancer -- Molecular Biology of Bladder Cancer -- Treatment Options in Superficial (pTA/pT1/CIS) Bladder Cancer -- Chemotherapy for Bladder Cancer -- Gene Therapy of Urothelial Malignancy -- Kidney Cancer -- Molecular Biology of Kidney Cancer -- Cytokine and Angiogenesis Inhibitors -- Novel Therapies for Renal Cell Cancer -- Testicular Cancer -- Genetics and Biology of Adult Male Germ Cell Tumors -- Chemotherapy for Testicular Cancer -- Surgery for Testicular Cancer -- Pathobiological Basis of Treatment Strategies of Germ Cell Tumors -- Penile Cancer -- A Scientific Understanding of the Development of Penile Tumors -- The Clinical Management of Penile Cancer -- Unusual Urological Tumors -- Oncocytomas and Rare Renal Tumors -- Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis.
Our understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations. This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists.
There are no comments for this item.